img

Patient Risk Capital Investment


Published on: 2024-01-04 | No of Pages : 151 | Industry : Service & Software

Publisher : MRA | Format : PDF&Excel

Patient Risk Capital Investment

The research team projects that the Patient Risk Capital Investment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2022 to 2027.



By Market Players

Accel

Benchmark Capital

First Round Capital

Lowercase Capital

Sequoia Capital

UNION SQUARE VENTURES

Andreessen Horowitz

Bessemer Venture Partners

Greylock Partners

Kleiner Perkins Caufield & Byers

Baseline Ventures

Breyer Capital

Founders Fund

Index Ventures

New Enterprise Associates



By Type

Early Stage Financing

Expansion Financing

Acquisition or Buyout Financing



By Application

High Technology Industries

Innovative Technology Company







Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.



The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Patient Risk Capital Investment 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product TypeThe report covers majority Product Types in the Patient Risk Capital Investment Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).

Markat Analysis by Application TypeBased on the Patient Risk Capital Investment Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report will provide with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



COVID-19 Impact

Report covers Impact of Coronavirus COVID-19Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Patient Risk Capital Investment market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Patient Risk Capital Investment Revenue

1.4 Market Analysis by Type

1.4.1 Global Patient Risk Capital Investment Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Early Stage Financing

1.4.3 Expansion Financing

1.4.4 Acquisition or Buyout Financing

1.5 Market by Application

1.5.1 Global Patient Risk Capital Investment Market Share by Application: 2022-2027

1.5.2 High Technology Industries

1.5.3 Innovative Technology Company

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Patient Risk Capital Investment Market Perspective (2022-2027)

2.2 Patient Risk Capital Investment Growth Trends by Regions

2.2.1 Patient Risk Capital Investment Market Size by Regions: 2016 VS 2022 VS 2027

2.2.2 Patient Risk Capital Investment Historic Market Size by Regions (2016-2021)

2.2.3 Patient Risk Capital Investment Forecasted Market Size by Regions (2022-2027)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Patient Risk Capital Investment Market Growth Strategy

3 Market Competition by Manufacturers

3.1 Global Patient Risk Capital Investment Production Capacity Market Share by Manufacturers (2016-2021)

3.2 Global Patient Risk Capital Investment Revenue Market Share by Manufacturers (2016-2021)

3.3 Global Patient Risk Capital Investment Average Price by Manufacturers (2016-2021)

3.4 Manufacturers Patient Risk Capital Investment Production Sites, Area Served, Product Type

4 Patient Risk Capital Investment Sales Market by Type (2016-2027)

4.1 Global Patient Risk Capital Investment Historic Market Size by Type (2016-2021)

4.2 Global Patient Risk Capital Investment Forecasted Market Size by Type (2022-2027)

5 Patient Risk Capital Investment Consumption Market by Application(2016-2027)

5.1 Global Patient Risk Capital Investment Historic Market Size by Application (2016-2021)

5.2 Global Patient Risk Capital Investment Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Patient Risk Capital Investment Market Size (2016-2027)

6.2 Patient Risk Capital Investment Key Players in North America (2016-2021)

6.3 North America Patient Risk Capital Investment Market Size by Type (2016-2021)

6.4 North America Patient Risk Capital Investment Market Size by Application (2016-2021)

7 East Asia

7.1 East Asia Patient Risk Capital Investment Market Size (2016-2027)

7.2 Patient Risk Capital Investment Key Players in East Asia (2016-2021)

7.3 East Asia Patient Risk Capital Investment Market Size by Type (2016-2021)

7.4 East Asia Patient Risk Capital Investment Market Size by Application (2016-2021)

8 Europe

8.1 Europe Patient Risk Capital Investment Market Size (2016-2027)

8.2 Patient Risk Capital Investment Key Players in Europe (2016-2021)

8.3 Europe Patient Risk Capital Investment Market Size by Type (2016-2021)

8.4 Europe Patient Risk Capital Investment Market Size by Application (2016-2021)

9 South Asia

9.1 South Asia Patient Risk Capital Investment Market Size (2016-2027)

9.2 Patient Risk Capital Investment Key Players in South Asia (2016-2021)

9.3 South Asia Patient Risk Capital Investment Market Size by Type (2016-2021)

9.4 South Asia Patient Risk Capital Investment Market Size by Application (2016-2021)

10 Southeast Asia

10.1 Southeast Asia Patient Risk Capital Investment Market Size (2016-2027)

10.2 Patient Risk Capital Investment Key Players in Southeast Asia (2016-2021)

10.3 Southeast Asia Patient Risk Capital Investment Market Size by Type (2016-2021)

10.4 Southeast Asia Patient Risk Capital Investment Market Size by Application (2016-2021)

11 Middle East

11.1 Middle East Patient Risk Capital Investment Market Size (2016-2027)

11.2 Patient Risk Capital Investment Key Players in Middle East (2016-2021)

11.3 Middle East Patient Risk Capital Investment Market Size by Type (2016-2021)

11.4 Middle East Patient Risk Capital Investment Market Size by Application (2016-2021)

12 Africa

12.1 Africa Patient Risk Capital Investment Market Size (2016-2027)

12.2 Patient Risk Capital Investment Key Players in Africa (2016-2021)

12.3 Africa Patient Risk Capital Investment Market Size by Type (2016-2021)

12.4 Africa Patient Risk Capital Investment Market Size by Application (2016-2021)

13 Oceania

13.1 Oceania Patient Risk Capital Investment Market Size (2016-2027)

13.2 Patient Risk Capital Investment Key Players in Oceania (2016-2021)

13.3 Oceania Patient Risk Capital Investment Market Size by Type (2016-2021)

13.4 Oceania Patient Risk Capital Investment Market Size by Application (2016-2021)

14 South America

14.1 South America Patient Risk Capital Investment Market Size (2016-2027)

14.2 Patient Risk Capital Investment Key Players in South America (2016-2021)

14.3 South America Patient Risk Capital Investment Market Size by Type (2016-2021)

14.4 South America Patient Risk Capital Investment Market Size by Application (2016-2021)

15 Rest of the World

15.1 Rest of the World Patient Risk Capital Investment Market Size (2016-2027)

15.2 Patient Risk Capital Investment Key Players in Rest of the World (2016-2021)

15.3 Rest of the World Patient Risk Capital Investment Market Size by Type (2016-2021)

15.4 Rest of the World Patient Risk Capital Investment Market Size by Application (2016-2021)

16 Company Profiles and Key Figures in Patient Risk Capital Investment Business

16.1 Accel

16.1.1 Accel Company Profile

16.1.2 Accel Patient Risk Capital Investment Product Specification

16.1.3 Accel Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 Benchmark Capital

16.2.1 Benchmark Capital Company Profile

16.2.2 Benchmark Capital Patient Risk Capital Investment Product Specification

16.2.3 Benchmark Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 First Round Capital

16.3.1 First Round Capital Company Profile

16.3.2 First Round Capital Patient Risk Capital Investment Product Specification

16.3.3 First Round Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 Lowercase Capital

16.4.1 Lowercase Capital Company Profile

16.4.2 Lowercase Capital Patient Risk Capital Investment Product Specification

16.4.3 Lowercase Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Sequoia Capital

16.5.1 Sequoia Capital Company Profile

16.5.2 Sequoia Capital Patient Risk Capital Investment Product Specification

16.5.3 Sequoia Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 UNION SQUARE VENTURES

16.6.1 UNION SQUARE VENTURES Company Profile

16.6.2 UNION SQUARE VENTURES Patient Risk Capital Investment Product Specification

16.6.3 UNION SQUARE VENTURES Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 Andreessen Horowitz

16.7.1 Andreessen Horowitz Company Profile

16.7.2 Andreessen Horowitz Patient Risk Capital Investment Product Specification

16.7.3 Andreessen Horowitz Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.8 Bessemer Venture Partners

16.8.1 Bessemer Venture Partners Company Profile

16.8.2 Bessemer Venture Partners Patient Risk Capital Investment Product Specification

16.8.3 Bessemer Venture Partners Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.9 Greylock Partners

16.9.1 Greylock Partners Company Profile

16.9.2 Greylock Partners Patient Risk Capital Investment Product Specification

16.9.3 Greylock Partners Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.10 Kleiner Perkins Caufield & Byers

16.10.1 Kleiner Perkins Caufield & Byers Company Profile

16.10.2 Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Product Specification

16.10.3 Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.11 Baseline Ventures

16.11.1 Baseline Ventures Company Profile

16.11.2 Baseline Ventures Patient Risk Capital Investment Product Specification

16.11.3 Baseline Ventures Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.12 Breyer Capital

16.12.1 Breyer Capital Company Profile

16.12.2 Breyer Capital Patient Risk Capital Investment Product Specification

16.12.3 Breyer Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.13 Founders Fund

16.13.1 Founders Fund Company Profile

16.13.2 Founders Fund Patient Risk Capital Investment Product Specification

16.13.3 Founders Fund Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.14 Index Ventures

16.14.1 Index Ventures Company Profile

16.14.2 Index Ventures Patient Risk Capital Investment Product Specification

16.14.3 Index Ventures Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.15 New Enterprise Associates

16.15.1 New Enterprise Associates Company Profile

16.15.2 New Enterprise Associates Patient Risk Capital Investment Product Specification

16.15.3 New Enterprise Associates Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer



List of Figure

Table 1. Key Players Covered: Ranking by Patient Risk Capital Investment Revenue (US$ Million) 2016-2021

Table 2. Global Patient Risk Capital Investment Market Size by Type (US$ Million): 2022-2027

Table 3. Global Patient Risk Capital Investment Market Size by Application (US$ Million): 2022-2027

Table 4. Global Patient Risk Capital Investment Market Size by Regions (US$ Million): 2022-2027

Table 5. Global Patient Risk Capital Investment Market Size by Regions (2016-2021) (US$ Million)

Table 6. Global Patient Risk Capital Investment Market Share by Regions (2016-2021)

Table 7. Global Patient Risk Capital Investment Forecasted Market Size by Regions (2022-2027) (US$ Million)

Table 8. Global Patient Risk Capital Investment Market Share by Regions (2022-2027)

Table 9. Market Top Trends

Table 10. Key Drivers: Impact Analysis

Table 11. Key Challenges

Table 12. Patient Risk Capital Investment Market Growth Strategy

Table 13. Global Patient Risk Capital Investment Production Capacity by Manufacturers

Table 14. Global Patient Risk Capital Investment Production by Manufacturers (2016-2021)

Table 15. Global Patient Risk Capital Investment Production Market Share by Manufacturers (2016-2021)

Table 16. Global Patient Risk Capital Investment Revenue by Manufacturers (2016-2021)

Table 17. Global Patient Risk Capital Investment Revenue Share by Manufacturers (2016-2021)

Table 18. Global Market Patient Risk Capital Investment Average Price of Key Manufacturers (2016-2021)

Table 19. Manufacturers Patient Risk Capital Investment Production Sites and Area Served

Table 20. Manufacturers Patient Risk Capital Investment Product Type

Table 21. Global Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 22. Global Patient Risk Capital Investment Revenue Market Share by Type (2016-2021)

Table 23. Global Patient Risk Capital Investment Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 24. Global Patient Risk Capital Investment Revenue Market Share by Type (2022-2027)

Table 25. Global Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 26. Global Patient Risk Capital Investment Revenue Market Share by Application (2016-2021)

Table 27. Global Patient Risk Capital Investment Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 28. Global Patient Risk Capital Investment Revenue Market Share by Application (2022-2027)

Table 29. North America Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 30. North America Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 31. North America Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 32. North America Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 33. North America Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 34. North America Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 35. East Asia Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 36. East Asia Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 37. East Asia Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 38. East Asia Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 39. East Asia Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 40. East Asia Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 41. Europe Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 42. Europe Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 43. Europe Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 44. Europe Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 45. Europe Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 46. Europe Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 47. South Asia Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 48. South Asia Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 49. South Asia Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 50. South Asia Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 51. South Asia Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 52. South Asia Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 53. Southeast Asia Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 54. Southeast Asia Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 55. Southeast Asia Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 56. Southeast Asia Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 57. Southeast Asia Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 58. Southeast Asia Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 59. Middle East Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 60. Middle East Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 61. Middle East Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 62. Middle East Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 63. Middle East Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 64. Middle East Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 65. Africa Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 66. Africa Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 67. Africa Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 68. Africa Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 69. Africa Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 70. Africa Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 71. Oceania Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 72. Oceania Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 73. Oceania Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 74. Oceania Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 75. Oceania Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 76. Oceania Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 77. South America Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 78. South America Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 79. South America Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 80. South America Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 81. South America Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 82. South America Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 83. Rest of the World Key Players Patient Risk Capital Investment Revenue (2016-2021) (US$ Million)

Table 84. Rest of the World Key Players Patient Risk Capital Investment Market Share (2016-2021)

Table 85. Rest of the World Patient Risk Capital Investment Market Size by Type (2016-2021) (US$ Million)

Table 86. Rest of the World Patient Risk Capital Investment Market Share by Type (2016-2021)

Table 87. Rest of the World Patient Risk Capital Investment Market Size by Application (2016-2021) (US$ Million)

Table 88. Rest of the World Patient Risk Capital Investment Market Share by Application (2016-2021)

Table 89. Accel Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 90. Benchmark Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 91. First Round Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 92. Table Lowercase Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 93. Sequoia Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 94. UNION SQUARE VENTURES Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 95. Andreessen Horowitz Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 96. Bessemer Venture Partners Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 97. Greylock Partners Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 98. Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 99. Baseline Ventures Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 100. Breyer Capital Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 101. Founders Fund Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 102. Index Ventures Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 103. New Enterprise Associates Patient Risk Capital Investment Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources





Figure 1. Global Patient Risk Capital Investment Market Share by Type: 2021 VS 2027

Figure 2. Early Stage Financing Features

Figure 3. Expansion Financing Features

Figure 4. Acquisition or Buyout Financing Features

Figure 11. Global Patient Risk Capital Investment Market Share by Application: 2021 VS 2027

Figure 12. High Technology Industries Case Studies

Figure 13. Innovative Technology Company Case Studies

Figure 21. Patient Risk Capital Investment Report Years Considered

Figure 22. Global Patient Risk Capital Investment Market Size YoY Growth 2022-2027 (US$ Million)

Figure 23. Global Patient Risk Capital Investment Market Share by Regions: 2022 VS 2027

Figure 24. Porter's Five Forces Analysis

Figure 25. North America Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 26. East Asia Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 27. Europe Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 28. South Asia Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 29. Southeast Asia Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 30. Middle East Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 31. Africa Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 32. Oceania Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 33. South America Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 34. Rest of the World Patient Risk Capital Investment Market Size YoY Growth (2016-2027) (US$ Million)

Figure 35. Accel Patient Risk Capital Investment Product Specification

Figure 36. Benchmark Capital Patient Risk Capital Investment Product Specification

Figure 37. First Round Capital Patient Risk Capital Investment Product Specification

Figure 38. Lowercase Capital Patient Risk Capital Investment Product Specification

Figure 39. Sequoia Capital Patient Risk Capital Investment Product Specification

Figure 40. UNION SQUARE VENTURES Patient Risk Capital Investment Product Specification

Figure 41. Andreessen Horowitz Patient Risk Capital Investment Product Specification

Figure 42. Bessemer Venture Partners Patient Risk Capital Investment Product Specification

Figure 43. Greylock Partners Patient Risk Capital Investment Product Specification

Figure 44. Kleiner Perkins Caufield & Byers Patient Risk Capital Investment Product Specification

Figure 45. Baseline Ventures Patient Risk Capital Investment Product Specification

Figure 46. Breyer Capital Patient Risk Capital Investment Product Specification

Figure 47. Founders Fund Patient Risk Capital Investment Product Specification

Figure 48. Index Ventures Patient Risk Capital Investment Product Specification

Figure 49. New Enterprise Associates Patient Risk Capital Investment Product Specification

Figure 85. Key Executives Interviewed